Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Heath

Showing results (131-140 of 248) with videos related to

Pageof 25
Sort By:
Surgical Endoscopy|June 20, 2000
The role of laparoscopy in preoperative staging of esophageal cancerE I Heath, H S Kaufman, M A Talamini, et al.
Clinical Prostate Cancer|March 30, 2004
The design of a randomized, placebo-controlled trial of celecoxib in preprostatectomy men with clinically localized adenocarcinoma of the prostateElisabeth I Heath, Theodore L DeWeese, Alan W Partin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2022
Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate CancerAnthony V Serritella, Daniel Shevrin, Elisabeth I Heath, et al.
Investigational New Drugs|November 20, 2015
A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) studyManish K Thakur, Lance K Heilbrun, Shijie Sheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
A phase I safety and pharmacologic study of a twice weekly dosing regimen of the oral taxane BMS-275183Linda E Bröker, Stephan A Veltkamp, Elisabeth I Heath, et al.
Investigational New Drugs|August 4, 2010
A phase 1 study of BMS-275183, a novel oral analogue of paclitaxel given on a daily schedule to patients with advanced malignanciesElisabeth I Heath, Patricia Lorusso, Suresh S Ramalingam, et al.
Journal of the National Cancer Institute|April 5, 2007
Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trialElisabeth I Heath, Marcia Irene Canto, Steven Piantadosi, et al.
JCO Precision Oncology|July 6, 2023
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene AlterationsDeborah B Doroshow, Peter H O'Donnell, Jean H Hoffman-Censits, et al.
American Journal of Translational Research|April 13, 2016
Anti-androgenic activity of absorption-enhanced 3, 3'-diindolylmethane in prostatectomy patientsClara Hwang, Seema Sethi, Lance K Heilbrun, et al.
Prostate Cancer and Prostatic Diseases|June 20, 2025
Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variantMayuko Kanayama, Emeline Colomba, Yusra Shao, et al.
Pageof 25

Showing results (131-140 of 248) with videos related to

Sort By:
Pageof 25
Surgical Endoscopy|June 20, 2000
The role of laparoscopy in preoperative staging of esophageal cancerE I Heath, H S Kaufman, M A Talamini, et al.
Clinical Prostate Cancer|March 30, 2004
The design of a randomized, placebo-controlled trial of celecoxib in preprostatectomy men with clinically localized adenocarcinoma of the prostateElisabeth I Heath, Theodore L DeWeese, Alan W Partin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2022
Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate CancerAnthony V Serritella, Daniel Shevrin, Elisabeth I Heath, et al.
Investigational New Drugs|November 20, 2015
A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) studyManish K Thakur, Lance K Heilbrun, Shijie Sheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
A phase I safety and pharmacologic study of a twice weekly dosing regimen of the oral taxane BMS-275183Linda E Bröker, Stephan A Veltkamp, Elisabeth I Heath, et al.
Investigational New Drugs|August 4, 2010
A phase 1 study of BMS-275183, a novel oral analogue of paclitaxel given on a daily schedule to patients with advanced malignanciesElisabeth I Heath, Patricia Lorusso, Suresh S Ramalingam, et al.
Journal of the National Cancer Institute|April 5, 2007
Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trialElisabeth I Heath, Marcia Irene Canto, Steven Piantadosi, et al.
JCO Precision Oncology|July 6, 2023
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene AlterationsDeborah B Doroshow, Peter H O'Donnell, Jean H Hoffman-Censits, et al.
American Journal of Translational Research|April 13, 2016
Anti-androgenic activity of absorption-enhanced 3, 3'-diindolylmethane in prostatectomy patientsClara Hwang, Seema Sethi, Lance K Heilbrun, et al.
Prostate Cancer and Prostatic Diseases|June 20, 2025
Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variantMayuko Kanayama, Emeline Colomba, Yusra Shao, et al.
Pageof 25